Zina Eminton
About
Zina Eminton is a scholar working on Pulmonary and Respiratory Medicine, Dermatology and Oncology.
According to data from OpenAlex, Zina Eminton has authored 19 papers receiving a total of 87 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Dermatology and 4 papers in Oncology. Recurrent topics in Zina Eminton's work include Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Acne and Rosacea Treatments and Effects (4 papers) and Dermatology and Skin Diseases (3 papers). Zina Eminton is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (4 papers), Acne and Rosacea Treatments and Effects (4 papers) and Dermatology and Skin Diseases (3 papers). Zina Eminton collaborates with scholars based in United Kingdom, United States and Germany. Zina Eminton's co-authors include Duncan McVey, Gareth Griffiths, Alison Layton, Matthew J Ridd, Nick Francis, Ingrid Müller, Paul Little, Kim S Thomas, Karen Thomas and Miriam Santer and has published in prestigious journals such as Journal of Clinical Oncology, BMJ and Annals of Oncology.
In The Last Decade
Zina Eminton
18 papers receiving 81 citations
Peers
Zina Eminton
Noah Vale Canada
Chiara Oriecuia Italy
Εleni Andreou Greece
Mihaiela L. Blaga Romania
Aline de Oliveira Ramalho Brazil
Pietro Calogero Italy
Saba Alvand Iran
Dhairya Nanavaty United States
E.Z.Z. Tan Malaysia
Muhammad Asad Parvaiz Pakistan
Citations per year, relative to Zina Eminton Zina Eminton (= 1×)
peers
Noah Vale
Countries citing papers authored by Zina Eminton
Since
Specialization
Citations
This map shows the geographic impact of Zina Eminton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zina Eminton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zina Eminton more than expected).
Fields of papers citing papers by Zina Eminton
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Zina Eminton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zina Eminton. The network helps show where Zina Eminton may publish in the future.
Co-authorship network of co-authors of Zina Eminton
This figure shows the co-authorship network connecting the top 25 collaborators of Zina Eminton. A scholar is included among the top collaborators of Zina Eminton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zina Eminton. Zina Eminton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Flett, Andrew, Zoe Nicholas, Robert Adam, et al.. (2025). BRITISH, an ongoing randomised trial of implantable defibrillators for non-ischemic cardiomyopathy with severe LV impairment and myocardial scar: trial design and update.. Journal of Cardiovascular Magnetic Resonance. 27. 101356–101356.
2.
Santer, Miriam, Beth Stuart, Tracey Sach, et al.. (2024). Clinical and cost-effectiveness of spironolactone in treating persistent facial acne in women: SAFA double-blinded RCT. Health Technology Assessment. 28(56). 1–86.
3.
Crabb, Simon J., Alannah Morgan, Evgenia Stefanopoulou, et al.. (2024). MANCAN2: A multicentre randomised controlled trial of self-help cognitive behavioural therapy (CBT) to manage hot flush and night sweats (HFNS) symptoms in patients with prostate cancer receiving androgen deprivation therapy (ADT).. Journal of Clinical Oncology. 42(17_suppl). LBA5004–LBA5004.
4.
Eminton, Zina, Jacqueline Nuttall, Christopher R Wilcox, et al.. (2023). Factors that influence women’s enrolment and ongoing participation in a partially decentralised randomised controlled dermatology trial: a qualitative interview study with participants in the SAFA (Spironolactone for Adult Female Acne) trial. Trials. 24(1). 661–661.
5.
Santer, Miriam, Zina Eminton, Beth Stuart, et al.. (2023). Effectiveness of spironolactone for women with acne vulgaris (SAFA) in England and Wales: pragmatic, multicentre, phase 3, double blind, randomised controlled trial. BMJ. 381. e074349–e074349.
6.
Flett, Andrew, Zoe Nicholas, Robert Adam, et al.. (2023). Rationale and study protocol for the BRITISH randomized trial (Using cardiovascular magnetic resonance identified scar as the benchmark risk indication tool for implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy and severe systolic heart failure). American Heart Journal. 266. 149–158.
7.
Crabb, Simon J., Alannah Morgan, Myra S. Hunter, et al.. (2023). A multicentre randomised controlled trial of a guided self-help cognitive behavioural therapy to MANage the impact of hot flushes and night sweats in patients with prostate CANcer undergoing androgen deprivation therapy (MANCAN2). Trials. 24(1). 450–450.
8.
Sach, Tracey, Zina Eminton, Beth Stuart, et al.. (2023). Cost-effectiveness of Spironolactone for Adult Female Acne (SAFA): economic evaluation alongside a randomised controlled trial. BMJ Open. 13(12). e073245–e073245.
9.
Fennell, Dean A., Daniel E. Griffiths, Zina Eminton, et al.. (2023). Evaluating niraparib versus active symptom control in patients with previously treated mesothelioma (NERO): a study protocol for a multicentre, randomised, two-arm, open-label phase II trial in UK secondary care centres. BMJ Open. 13(11). e073120–e073120.
10.
Griffiths, Gareth, Daniel E. Griffiths, Zina Eminton, et al.. (2023). A randomised phase II trial of niraparib versus active symptom control in patients with previously treated mesothelioma: NERO.. Journal of Clinical Oncology. 41(16_suppl). TPS8600–TPS8600.
11.
Pugh, S., Enric Domingo, Susan D. Richman, et al.. (2023). Analysis of primary and acquired resistance to cetuximab from multiomic data in the New EPOC trial.. Journal of Clinical Oncology. 41(16_suppl). 3577–3577.
12.
Aldrighetti, Luca, Roberto Troisi, Mohammad Abu Hilal, et al.. (2021). 384O Laparoscopic versus open hemihepatectomy: The ORANGE II PLUS multicenter randomized controlled trial. Annals of Oncology. 32. S531–S531.
13.
Stuart, Beth, Ingrid Müller, Irene Soulsby, et al.. (2021). Spironolactone for adult female acne (SAFA): protocol for a double-blind, placebo-controlled, phase III randomised study of spironolactone as systemic therapy for acne in adult women. BMJ Open. 11(8). e053876–e053876.
14.
Buchanan, Ryan, Kinda Ibrahim, Helen C. Roberts, et al.. (2021). Nasal irrigation and gargling with hypertonic saline to prevent transmission of Sars-CoV-2 to care home residents – a feasibility cluster trial. ePrints Soton (University of Southampton). 1–4.
15.
Bridgewater, John, S. Pugh, Amy Whitehead, et al.. (2017). Perioperative chemotherapy with or without cetuximab in patients (pts) with resectable colorectal liver metastasis (CRLM): Mature analysis of overall survival (OS) in the New EPOC randomised controlled trial. Annals of Oncology. 28. v162–v162.
16.
Goldstein, D., Jonathan Fawcett, John Bridgewater, et al.. (2015). 2044 Feasibility of trials to assess safety and toxicity of peri-operative and post-operative adjuvant therapy for hepatic metastases from colorectal cancer. European Journal of Cancer. 51. S343–S343.
17.
Fowler, G. Herbert, et al.. (1999). AN ASSESSMENT OF THE EFFICACY OF ATORVASTATIN IN ACHIEVING LDL CHOLESTEROL TARGET LEVELS IN PATIENTS WITH CORONARY HEART DISEASE: A GENERAL PRACTICE STUDY. International Journal of Clinical Practice. 53(6). 422–426.
18.
McVey, Duncan, et al.. (1999). AN ASSESSMENT OF THE EFFICACY OF ATORVASTATIN IN TREATING PATIENTS WITH DYSLIPIDAEMIA TO TARGET LDL‐CHOLESTEROL GOALS: THE ATORVASTATIN MATRIX STUDY. International Journal of Clinical Practice. 53(7). 509–513.
19.
Maclean, Derek, et al.. (1993). THE INCIDENCE OF FIRST‐DOSE HYPOTENSION WITH QUINAPRIL IN PATIENTS WITH MILD TO MODERATE HYPERTENSION. International Journal of Clinical Practice. 47(5). 234–236.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Noah Vale Breakdown of academic impact, for papers by Chiara Oriecuia Breakdown of academic impact, for papers by Εleni Andreou Breakdown of academic impact, for papers by Mihaiela L. Blaga Breakdown of academic impact, for papers by Aline de Oliveira Ramalho Breakdown of academic impact, for papers by Pietro Calogero Breakdown of academic impact, for papers by Saba Alvand Breakdown of academic impact, for papers by Dhairya Nanavaty Breakdown of academic impact, for papers by E.Z.Z. Tan Breakdown of academic impact, for papers by Muhammad Asad Parvaiz